Stock listing

BOATS:LUCD Lucid Diagnostics Inc. Stock

US listing (BOATS) of Lucid Diagnostics Inc. · home listing NASDAQ:LUCD

Follow Lucid Diagnostics Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:LUCD

$0.373 USD -0.035 (-8.6%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LUCD

Past year -63.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.355 – $0.395 USDNov 20, 2026
Volume
2.26M sharesNov 20, 2026
Market cap
$77.14M USDAt the close on Nov 20, 2026 · price × 207.0M shares outstanding
52-week range
$0.303 – $1.629 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.37M USDMedian day 1.64M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Lucid Diagnostics Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LUCD · Home$0.373 USD-0.035 (-8.6%)2,261,958$0.380$0.395$0.355$0.408Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LUCD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.373-0.035-8.6%$0.380$0.395$0.3552,261,958
$0.408+0.009+2.2%$0.405$0.417$0.3722,703,842
$0.399+0.001+0.3%$0.400$0.404$0.3702,149,543
$0.398-0.051-11.4%$0.458$0.465$0.3912,169,849
$0.449+0.033+7.9%$0.444$0.492$0.4233,460,638
$0.416+0.035+9.2%$0.400$0.430$0.3832,358,379
$0.381-0.019-4.7%$0.410$0.420$0.3731,740,179
$0.400-0.017-4.2%$0.423$0.430$0.3951,386,685
$0.418+0.019+4.9%$0.395$0.426$0.3951,644,978
$0.398+0.008+2.0%$0.387$0.401$0.3851,262,773
$0.390-0.055-12.4%$0.449$0.449$0.3902,026,558
$0.445+0.036+8.8%$0.411$0.478$0.4073,548,164
$0.409+0.003+0.7%$0.400$0.434$0.3961,613,909
$0.406+0.002+0.4%$0.405$0.411$0.3931,333,060
$0.405-0.028-6.4%$0.415$0.440$0.4031,706,040
$0.432+0.021+5.0%$0.412$0.456$0.4035,052,427
$0.412-0.026-6.0%$0.438$0.440$0.3806,315,332
$0.438-0.063-12.5%$0.520$0.546$0.41510,226,161
$0.501+0.090+21.8%$0.416$0.560$0.40643,499,882
$0.411+0.083+25.4%$0.434$0.453$0.388111,802,493
$0.328-0.006-1.7%$0.321$0.330$0.30348,099,609
$0.333-0.019-5.3%$0.360$0.393$0.3213,688,715
$0.352-0.026-6.8%$0.368$0.375$0.3036,330,013
$0.377-0.101-21.0%$0.480$0.480$0.3584,274,411
$0.478-0.042-8.1%$0.522$0.526$0.4702,335,027
$0.520-0.023-4.2%$0.544$0.569$0.5103,007,774
$0.543-0.063-10.4%$0.591$0.618$0.5401,818,047
$0.606+0.009+1.4%$0.600$0.620$0.5771,096,500
$0.597-0.041-6.4%$0.632$0.660$0.5971,635,460
$0.638-0.012-1.9%$0.650$0.690$0.6211,947,148
$0.650+0.027+4.3%$0.610$0.674$0.6032,509,163
$0.624+0.024+3.9%$0.591$0.653$0.5881,712,838
$0.600+0.007+1.1%$0.600$0.611$0.5801,458,836
$0.593-0.034-5.4%$0.623$0.676$0.5901,833,001
$0.627-0.008-1.2%$0.635$0.675$0.6252,255,357
$0.635-0.116-15.5%$0.723$0.725$0.5006,786,100
$0.751-0.058-7.2%$0.815$0.815$0.7401,776,965
$0.809+0.003+0.4%$0.810$0.834$0.800771,675
$0.806-0.020-2.5%$0.820$0.827$0.803786,366
$0.826-0.012-1.4%$0.843$0.849$0.8161,188,948
$0.838-0.001-0.1%$0.834$0.877$0.8201,132,937
$0.839-0.054-6.0%$0.885$0.900$0.821945,099
$0.893+0.047+5.6%$0.855$0.907$0.8321,525,367
$0.845+0.059+7.6%$0.793$0.850$0.7741,393,727
$0.786+0.005+0.7%$0.800$0.800$0.7662,402,878
$0.780-0.056-6.7%$0.823$0.843$0.7501,282,822
$0.836+0.043+5.4%$0.787$0.844$0.7771,274,214
$0.794+0.011+1.4%$0.782$0.800$0.7501,250,488
$0.7830.0000.0%$0.779$0.798$0.774958,674
$0.783-0.021-2.6%$0.848$0.856$0.7801,223,979
$0.804-0.017-2.1%$0.830$0.830$0.7891,254,414
$0.821-0.076-8.4%$0.901$0.915$0.8121,779,452
$0.897-0.043-4.5%$0.935$0.935$0.891964,588
$0.940-0.012-1.2%$0.941$0.959$0.9271,016,800
$0.951-0.039-3.9%$0.984$0.989$0.940837,646
$0.990+0.016+1.6%$0.960$0.993$0.957636,514
$0.974-0.005-0.5%$0.970$0.999$0.962449,013
$0.979-0.013-1.3%$0.990$1.010$0.974423,399
$0.991+0.007+0.8%$0.985$1.000$0.972426,794
$0.984+0.013+1.4%$0.962$1.019$0.960966,858
$0.971-0.039-3.9%$1.000$1.015$0.960834,240
$1.010+0.010+1.0%$1.000$1.040$0.9901,108,666
$1.000+0.036+3.7%$0.968$1.020$0.951645,664
$0.964+0.004+0.4%$0.970$0.983$0.940415,411
$0.960-0.050-4.9%$0.999$1.010$0.958980,470
Ticker
BOATS:LUCD
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All Lucid Diagnostics Inc. news

Lucid Diagnostics Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
20 in the last 12 months · 128 in all · newest Nov 12, 2026 · oldest 2021
Calls
20 calls with a replay · 20 with a transcript · latest Nov 12, 2026
Decks
12 decks · latest Nov 12, 2026

Where Lucid Diagnostics Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:LUCD · Home listingNASDAQUnited StatesUSD
BOATS:LUCD · This pageBOATSUnited StatesUSD

Valuation

EV/sales 14.3× against a median of 4.3×: 10th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$77.63M USD
P/E
Loss
EV/sales
14.3×
EV/EBITDA
Negative EBITDA
Price/book
13.0×
Gross margin
−20.6%
Operating margin
−941.7%
Net margin
−892.8%
Debt to equity
3.1×
Beta vs S&P 500
1.36

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Lucid Diagnostics Inc. · NASDAQ:LUCDUS$77.14MUS$77.63Mn/a14.3×n/a13.0×−892.8%3.1×1.36
Exagen Inc. · NASDAQ:XGNUS$92.10MUS$86.82Mn/a1.2×n/a6.7×−25.1%1.7×2.52
Biodesix, Inc. · NASDAQ:BDSXUS$83.83MUS$105.4Mn/a1.0×n/a9.7×−25.7%5.8×1.56
Bonraybio Co. Ltd. · TWSE:6955US$81.85MUS$65.60M25.0×6.5×18.1×4.1×32.5%0.0×n/a
Nightingale Health Oyj Class B · OMXHEX:HEALTHUS$77.17MUS$36.79Mn/a6.1×n/a1.4×−335.7%0.0×n/a
Seer, Inc. · NASDAQ:SEERUS$75.91M−US$58.25Mn/a−4.1×n/a0.4×−450.9%0.1×1.03
Selvita SA · GPW:SLVUS$75.24MUS$113.4Mn/a1.4×9.1×1.0×−0.6%0.5×n/a
Sera Prognostics, Inc. · NASDAQ:SERAUS$69.65MUS$28.84Mn/a300×n/a1.3×n/a0.1×0.57
BioPorto A/S · OMXCOP:BIOPORUS$68.30MUS$58.06M53.8×10.7×n/a5.7×23.3%0.1×n/a
Nanoform Finland Oyj · OMXHEX:NANOFHUS$66.63MUS$52.80Mn/a11.9×n/a1.7×−339.1%0.2×n/a
Applied BioCode Corp. · TWSE:6598US$64.88MUS$49.53Mn/a2.5×n/a3.0×−7.3%0.1×n/a
Median of the othersUS$75.58MUS$55.43M39.4×4.3×13.6×2.4×−25.1%0.1×1.30

Forecasts

3 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
4.50 USD · Analysts' mean
EPS, year to Dec 2026
-0.24 · 2 analysts
Revenue, year to Dec 2026
5.7M · 1 analyst

Team and board

Officers

OfficerRole
Lishan AklogChairman, Chief Executive Officer
Dennis McGrathChief Financial Officer
Shaun O'NeilPresident & Chief Operating Officer
Michael GordonGeneral Counsel & Corporate Secretary
Deepika A. LakhaniSenior Vice President, Chief Regulatory & Quality Officer
Suman M. VermaSenior Vice President, Chief Scientific Officer
Victoria T. LeeExecutive Vice President, Chief Medical Officer
Brian deGuzmanChief Technology & Compliance Officer

Board

DirectorRole
Lishan AklogChairman, Chief Executive Officer
Debbie White
Dennis MatheisBoard Member
Jacque J. SokolovBoard Member
James L. CoxBoard Member
John R. PalumboBoard Member
Ron Sparks
Stanley N. LapidusVice-Chairman

Events

Calls

CallWhenStatus
Lucid Diagnostics (NASDAQ:LUCD) Q3 2026 Earnings CallThu, Nov 12, 2026 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q2 2026 Earnings CallThu, Aug 13, 2026 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q1 2026 Earnings CallThu, May 14, 2026 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q4 2025 Earnings CallThu, Mar 26, 2026 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q3 2025 Earnings CallWed, Nov 12, 2025 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q2 2025 Earnings CallWed, Aug 13, 2025 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q1 2025 Earnings CallWed, May 14, 2025 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q4 2024 Earnings CallMon, Mar 24, 2025 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q3 2024 Earnings CallWed, Nov 13, 2024 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q2 2024 Earnings CallMon, Aug 12, 2024 · 8:30 AM ETReplay
All 20 calls
CallWhenStatus
Lucid Diagnostics (NASDAQ:LUCD) Q1 2024 Earnings CallMon, May 13, 2024 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q4 2023 Earnings CallTue, Mar 26, 2024 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q3 2023 Earnings CallTue, Nov 14, 2023 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q2 2023 Earnings CallTue, Aug 15, 2023 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q1 2023 Earnings CallTue, May 16, 2023 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q4 2022 Earnings CallTue, Mar 14, 2023 · 8:30 AM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q3 2022 Earnings CallMon, Nov 14, 2022 · 4:30 PM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q2 2022 Earnings CallMon, Aug 15, 2022 · 4:30 PM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q1 2022 Earnings CallMon, Apr 04, 2022 · 4:30 PM ETReplay
Lucid Diagnostics (NASDAQ:LUCD) Q4 2021 Earnings CallMon, Mar 28, 2022 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 12, 2026 · Before open+9.2%
Q2 2026Aug 13, 2026 · Before open−2.0%
Q1 2026May 13, 2026 · After close0.0%
Q4 2025Mar 30, 2026+2.7%
Q3 2025Nov 12, 2025 · Before open+6.7%
Q2 2025Aug 12, 2025 · After close−1.6%
Q1 2025May 13, 2025 · After close+7.6%
Q4 2024Mar 24, 2025+2.0%
Q3 2024Nov 12, 2024 · After close+5.0%
Q2 2024Aug 12, 2024 · Before open+6.3%
All 20 quarters
QuarterResultsShare move
Q1 2024May 13, 2024 · Before open+0.6%
Q4 2023Mar 25, 2024 · After close−6.6%
Q3 2023Nov 13, 2023 · After close+12.1%
Q2 2023Aug 14, 2023 · After close+0.3%
Q1 2023May 15, 2023 · After close+0.7%
Q4 2022Mar 13, 2023 · After close+6.8%
Q3 2022Nov 14, 2022 · After close−11.9%
Q2 2022Aug 15, 2022 · After close−2.1%
Q1 2022May 11, 2022 · After close+5.9%
Q4 2021Mar 28, 2022 · After close+6.6%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings15 slidesNov 12, 2026
Q2 2026 Earnings PresentationEarnings12 slidesAug 13, 2026
Q1 2026 Earnings PresentationEarnings28 slidesMay 14, 2026
Q4 2025 Earnings PresentationEarnings13 slidesMar 26, 2026
Q1 2025 Earnings PresentationEarnings14 slidesMay 14, 2025
Q4 2024 Earnings PresentationEarnings16 slidesMar 24, 2025
Q3 2024 Earnings PresentationEarnings20 slidesNov 13, 2024
Q2 2024 Earnings PresentationEarnings22 slidesAug 12, 2024
Q1 2024 Earnings PresentationEarnings22 slidesMay 13, 2024
Q4 2023 Earnings PresentationEarnings21 slidesMar 26, 2024
All 12 decks
DeckKindSlidesDate
Q3 2023 Earnings PresentationEarnings19 slidesNov 14, 2023
Q2 2023 Earnings PresentationEarnings19 slidesAug 15, 2023

Open Decks

Financings

RaiseDate
Private placement of series C Convertible Preferred Stock
Closed: US$15M raised · US$1,000 a share
Buyers: Holders of a majority of the Company's 12.0% senior secured convertible notes due 2029
Use of proceeds: To accelerate near-term commercial operations and for working capital and general corporate purposes
Oct 22, 2026
Registered direct offering of common shares
Closed: US$18M raised · US$1 a share · Canaccord Genuity LLC +1
Dealers: Canaccord Genuity LLC (co-lead), BTIG, LLC (co-lead)
Buyers: fundamental institutional investor ($15 million investment)
Use of proceeds: Working capital and general corporate purposes
Apr 24, 2026
Public offering of common stock
Closed: US$26.9M raised · US$1 a share · Canaccord Genuity LLC +2
Dealers: Canaccord Genuity LLC (co-lead), BTIG, LLC (co-lead), Maxim Group LLC
Use of proceeds: Working capital and general corporate purposes
Sep 11, 2025
Public offering of common stock
Closed: US$16.1M raised
May 14, 2025
Registered direct offering of shares of common stock
Closed: US$15.3M raised · US$1.1 a share · Canaccord Genuity
Dealers: Canaccord Genuity (lead)
Use of proceeds: Working capital and other general corporate purposes
Mar 5, 2025
Five-year convertible notes
Closed: US$21.95M raised
Use of proceeds: $3.61 million used to retire existing convertible debt; remainder adds cash to extend runway past reimbursement milestones
Dec 3, 2024

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$14.00 a share on Oct 13, 2021.

Price
US$14.00 a share
Shares offered
5,000,000 shares of common stock
Offering size
US$70 million
Underwriters' option
Up to 750,000 more shares
Listing
LUCD on Nasdaq
Underwriters
Cantor, Canaccord Genuity, BTIG, Needham & Company · In the order on the cover
Shares delivered
On or about Oct 18, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceJan 21, 2020
Filed publiclySep 22, 2021
Amended 3 timesNewest Oct 8, 2021
Shares registered with an exchangeOct 12, 2021
Declared effective by the SECOct 13, 2021
Final prospectus, with the priceOct 15, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Oct 15, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue4.71M4.35M2.43M377.0K500.0K00
Cost of revenue6.67M7.10M8.48M100.0M585.0K0
Gross profit-2.84M-3.92M-6.05M377.0K500.0K0
Research and development5.68M5.99M7.25M11.3M9.30M5.44M3.46M715.6K
Selling, general and administrative23.9B20.2B19.3M23.7M21.0K7.00K958.7K615.4K
Operating income-49.6M-46.1M-48.5M-56.3M-27.4M-8.28M-4.42M-1.13M
Depreciation and amortization872.0K1.17M2.50M1.94M4.00K8.28M4.42M1.69M
EBITDA-48.8M-44.9M-46.0M-54.3M-27.4M-10562.9K
Interest expense22.0K26.0K416.0K8.00K659.0K000
Income before tax-58.0M-45.5M-52.7M-56.2M-28.1M-8.28M-4.42M-1.13M
Income tax002.33M1.71M659.0K-8.28M-4.42M-1.69M
Net income-58.0M-45.5M-52.7M-56.2M-28.1M-8.28M-4.42M-1.13M
Earnings per share, basic-0.69-1.05-1.26-1.55-1.51-0.59-0.12-0.03
Earnings per share, diluted-1.05-1.26-1.55-1.51-0.59

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents34.7M22.4M18.9M22.5M53.7M111.0K156.4K17.8K
Short-term investments1.33M1.12M118.0K118.1K
Receivables643.0K45.0K45.0K17.0K200.0K1
Inventory353.0K341.0K278.0K111.0K493.0K834.0K0
Current assets37.5M25.1M22.1M24.4M57.3M1.44M390.9K17.8K
Property, plant and equipment809.0K1.06M1.33M1.59M971.0K
Goodwill735.3M
Total assets40.4M30.7M27.3M32.5M59.0M2.19M1.03M17.8K
Accounts payable970.0K1.24M1.15M1.06M1.49M2.06M799.1K497.2K
Current liabilities28.6M23.5M29.4M8.43M4.26M15.7M6.34M1.08M
Total debt25.8M21.3M15.3M2.00M13.3M
Total liabilities29.5M25.3M29.6M9.46M4.26M15.7M6.34M1.08M
Shareholders' equity10.9M5.39M-2.31M23.0M54.7M-13.5M-5.31M-1.06M
Shares outstanding131.1M63.1M42.3M40.5M34.9M14.1M37.0M37.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-46.5M-44.1M-32.8M-29.7M-17.7M-5.63M-2.36M-170.6K
Capital spending-197.0K-296.0K-221.0K-3.20M-862.0K-862.0K-4-862.0K
Free cash flow-46.7M-44.4M-33.0M-32.9M-18.5M-5.63M-2.36M-113.7K
Cash from investing-197.0K-646.0K-221.0K-4.11M-862.0K-862.0K-862.0K-862.0K
Cash from financing59.0M48.2M29.5M2.61M72.1M5.58M2.50M131.5K
Share buybacks272.0M447.0M551.0M109.0M
Change in cash12.3M3.46M-3.58M-31.2M53.5M-45.0K138.6K17.8K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportNov 12, 2026ResultsSEC
8-K · Current reportOct 22, 2026FinancingSEC
8-K · Current reportOct 16, 2026Current reportSEC
8-K · Current reportSep 22, 2026Current reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
8-K · Current reportJun 24, 2026Meeting outcomeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
8-K · Current reportMay 14, 2026ResultsSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
DEFA14A · Additional proxy materialApr 30, 2026Meeting noticeSEC
ARS · Annual report to shareholdersApr 30, 2026Annual reportSEC
DEF 14A · Proxy statementApr 30, 2026Meeting noticeSEC
3/A · Initial statement of ownership, amendedApr 24, 2026Insider tradeSEC
8-K · Current reportApr 24, 2026Current reportSEC
424B5 · ProspectusApr 23, 2026Offer documentSEC
8-K · Current reportApr 23, 2026Material contractSEC
PRE 14A · Preliminary proxy statementApr 20, 2026Meeting noticeSEC
3 · Initial statement of ownershipApr 13, 2026Insider tradeSEC
S-8 · Registration statement for employee plansApr 2, 2026Offer documentSEC
S-8 · Registration statement for employee plansApr 2, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveMar 27, 2026Other filingsSEC
424B5 · ProspectusMar 26, 2026Offer documentSEC
8-K · Current reportMar 26, 2026ResultsSEC
CORRESP · Letter to the SECMar 25, 2026Other filingsSEC
S-3/A · Registration statement, amendedMar 25, 2026Offer documentSEC
10-K · Annual reportMar 25, 2026Annual reportSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 9, 2026Big-stake noticeSEC
S-3 · Registration statementDec 5, 2025Offer documentSEC
8-K · Current reportNov 12, 2025ResultsSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 10, 2025Big-stake noticeSEC
4 · Change in ownershipOct 7, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 7, 2025Insider tradeSEC
8-K · Current reportSep 25, 2025Management or board changeSEC
8-K · Current reportSep 11, 2025Current reportSEC
424B5 · ProspectusSep 10, 2025Offer documentSEC
8-K · Current reportSep 10, 2025Material contractSEC
424B5 · ProspectusSep 9, 2025Offer documentSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
8-K · Current reportAug 13, 2025ResultsSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
8-K · Current reportJun 18, 2025Meeting outcomeSEC
424B3 · ProspectusJun 3, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveJun 2, 2025Other filingsSEC
8-K · Current reportMay 30, 2025Material contractSEC
424B5 · ProspectusMay 30, 2025Offer documentSEC
CORRESP · Letter to the SECMay 27, 2025Other filingsSEC
UPLOAD · Letter from the SECMay 27, 2025Other filingsSEC
4/A · Change in ownership, amendedMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
S-3 · Registration statementMay 21, 2025Offer documentSEC
8-K · Current reportMay 14, 2025ResultsSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
DEFA14A · Additional proxy materialApr 30, 2025Meeting noticeSEC
ARS · Annual report to shareholdersApr 30, 2025Annual reportSEC
DEF 14A · Proxy statementApr 30, 2025Meeting noticeSEC
8-K · Current reportApr 25, 2025Current reportSEC
PRE 14A · Preliminary proxy statementApr 18, 2025Meeting noticeSEC
8-K · Current reportApr 11, 2025Current reportSEC
424B5 · ProspectusApr 10, 2025Offer documentSEC
8-K · Current reportApr 10, 2025Material contractSEC
424B5 · ProspectusApr 9, 2025Offer documentSEC
8-K · Current reportMar 25, 2025ResultsSEC
10-K · Annual reportMar 24, 2025Annual reportSEC
8-K · Current reportMar 5, 2025Current reportSEC
424B5 · ProspectusMar 5, 2025Offer documentSEC
8-K · Current reportMar 4, 2025Material contractSEC
8-K · Current reportMar 4, 2025Current reportSEC
8-K · Current reportFeb 24, 2025Current reportSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
4 · Change in ownershipFeb 21, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
S-8 · Registration statement for employee plansJan 31, 2025Offer documentSEC
S-8 · Registration statement for employee plansJan 31, 2025Offer documentSEC
8-K · Current reportDec 20, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedDec 12, 2024Big-stake noticeSEC
DDec 6, 2024Other filingsSEC
8-K · Current reportNov 29, 2024Material contractSEC
8-K · Current reportNov 18, 2024Material contractSEC
8-K · Current reportNov 13, 2024ResultsSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K · Current reportNov 12, 2024Material contractSEC
10-Q · Quarterly reportAug 12, 2024Quarterly reportSEC
8-K · Current reportAug 12, 2024ResultsSEC
8-K · Current reportJul 23, 2024Meeting outcomeSEC
424B3 · ProspectusJul 19, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 19, 2024Other filingsSEC
CORRESP · Letter to the SECJul 15, 2024Other filingsSEC
S-3/A · Registration statement, amendedJul 12, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedJul 8, 2024Big-stake noticeSEC
UPLOAD · Letter from the SECJul 8, 2024Other filingsSEC
S-3 · Registration statementJul 1, 2024Offer documentSEC
8-K · Current reportJun 21, 2024Current reportSEC
DEF 14A · Proxy statementJun 6, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialJun 6, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementMay 24, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialMay 24, 2024Meeting noticeSEC
8-K · Current reportMay 24, 2024Current reportSEC
8-K · Current reportMay 14, 2024ResultsSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
4 · Change in ownershipMay 9, 2024Insider tradeSEC
3 · Initial statement of ownershipMay 9, 2024Insider tradeSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
8-K · Current reportMay 7, 2024Management or board changeSEC
8-K · Current reportMay 2, 2024Current reportSEC
DEFA14A · Additional proxy materialApr 29, 2024Meeting noticeSEC
ARS · Annual report to shareholdersApr 29, 2024Annual reportSEC
DEF 14A · Proxy statementApr 29, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 18, 2024Meeting noticeSEC
10-K · Annual reportMar 25, 2024Annual reportSEC
8-K · Current reportMar 14, 2024FinancingSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 20, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedFeb 20, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansFeb 6, 2024Offer documentSEC
S-8 · Registration statement for employee plansFeb 6, 2024Offer documentSEC
SC 13D/A · Big-stake notice, amendedFeb 2, 2024Big-stake noticeSEC
4 · Change in ownershipJan 30, 2024Insider tradeSEC
8-K · Current reportJan 30, 2024FinancingSEC
8-K · Current reportNov 28, 2023Current reportSEC
8-K · Current reportNov 24, 2023Current reportSEC
8-K · Current reportNov 13, 2023ResultsSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
8-K · Current reportNov 13, 2023Management or board changeSEC
DNov 1, 2023Other filingsSEC
8-K · Current reportOct 18, 2023FinancingSEC
4 · Change in ownershipSep 27, 2023Insider tradeSEC
4/A · Change in ownership, amendedSep 27, 2023Insider tradeSEC
144 · Notice of proposed saleSep 26, 2023Other filingsSEC
4 · Change in ownershipSep 22, 2023Insider tradeSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
8-K · Current reportJun 21, 2023Meeting outcomeSEC
EFFECT · Notice that a registration is effectiveJun 2, 2023Other filingsSEC
424B3 · ProspectusJun 1, 2023Offer documentSEC
CORRESP · Letter to the SECMay 26, 2023Other filingsSEC
UPLOAD · Letter from the SECMay 26, 2023Other filingsSEC
S-3 · Registration statementMay 22, 2023Offer documentSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
DEFA14A · Additional proxy materialMay 1, 2023Meeting noticeSEC
DEF 14A · Proxy statementMay 1, 2023Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 19, 2023Meeting noticeSEC
4/A · Change in ownership, amendedApr 13, 2023Insider tradeSEC
3 · Initial statement of ownershipApr 6, 2023Insider tradeSEC
DApr 5, 2023Other filingsSEC
8-K · Current reportApr 3, 2023Current reportSEC
8-K · Current reportMar 24, 2023Material contractSEC
SC 13G/A · Big-stake notice, amendedMar 24, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeMar 23, 2023Big-stake noticeSEC
DMar 22, 2023Other filingsSEC
8-K · Current reportMar 14, 2023ResultsSEC
10-K · Annual reportMar 13, 2023Annual reportSEC
8-K · Current reportMar 13, 2023FinancingSEC
8-K · Current reportFeb 17, 2023FinancingSEC
8-K · Current reportFeb 16, 2023Current reportSEC
S-8 · Registration statement for employee plansFeb 10, 2023Offer documentSEC
S-8 · Registration statement for employee plansFeb 10, 2023Offer documentSEC
4 · Change in ownershipFeb 2, 2023Insider tradeSEC
4 · Change in ownershipFeb 2, 2023Insider tradeSEC
4 · Change in ownershipFeb 2, 2023Insider tradeSEC
4 · Change in ownershipFeb 2, 2023Insider tradeSEC
4 · Change in ownershipFeb 2, 2023Insider tradeSEC
8-K · Current reportJan 18, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveDec 7, 2022Other filingsSEC
424B5 · ProspectusDec 6, 2022Offer documentSEC
4 · Change in ownershipDec 2, 2022Insider tradeSEC
SC 13D/A · Big-stake notice, amendedDec 2, 2022Big-stake noticeSEC
8-K · Current reportDec 2, 2022FinancingSEC
CORRESP · Letter to the SECDec 1, 2022Other filingsSEC
UPLOAD · Letter from the SECDec 1, 2022Other filingsSEC
S-3 · Registration statementNov 23, 2022Offer documentSEC
8-K · Current reportNov 14, 2022ResultsSEC

This page holds 200 of 283 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Lucid Diagnostics Inc.’s releases · as of Nov 10, 2026

Common shares
206,977,800
Fully diluted
206,977,800

Fully diluted

LineSharesAs of
Common shares206,977,800Nov 10, 2026

Share count over time

CountShares
Nov 10, 2026206,977,800

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
BlackRock8.39M4.1%US$6.3M+14,762Nov 13, 2026
Vanguard8.15M3.9%US$6.12M−517KNov 13, 2026
Alyeska Investment Group, L.P.7.97M3.9%US$5.99M−887KNov 16, 2026
Two Seas Capital LP6M2.9%US$4.51MNo changeOct 6, 2026
abrdn4.42M2.1%US$3.32M+597KNov 10, 2026
Masters Capital Management LLC4M1.9%US$3MNo changeNov 16, 2026
Geode Capital3.57M1.7%US$2.68M−224KNov 6, 2026
Wells Fargo2.54M1.2%US$1.9M+469KNov 16, 2026
State Street2.44M1.2%US$1.83M+4,883Nov 12, 2026
First Manhattan Co. LLC.2.19M1.1%US$1.64MNo changeNov 16, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Northern Trust1.24M0.60%US$928K+16,137Nov 16, 2026
UBS1.14M0.55%US$860K+300KNov 10, 2026
Perkins Capital Management Inc1.13M0.54%US$845KNo changeNov 2, 2026
Citadel645K0.31%US$484K+608KNov 16, 2026
Raymond James Financial Inc577K0.28%US$434KNo changeNov 12, 2026
Lido Advisors, LLC447K0.22%US$335K−28Nov 4, 2026
Schwab407K0.20%US$306K+81,688Nov 16, 2026
Rothschild Capital Partners, LLC372K0.18%US$280KNewNov 16, 2026
XTX Topco Ltd343K0.17%US$257KNewNov 16, 2026
XML Financial, LLC323K0.16%US$243KNo changeOct 29, 2026
BNY313K0.15%US$235K+11,771Nov 5, 2026
Nuveen301K0.15%US$226K+106KNov 10, 2026
BMO290K0.14%US$218KNo changeNov 9, 2026
Focus Partners Wealth184K0.09%US$138K+35,003Nov 12, 2026
Tripletail Wealth Management, LLC183K0.09%US$138KNo changeNov 16, 2026
Squarepoint Ops LLC170K0.08%US$127KNewNov 9, 2026
Bank of America162K0.08%US$122K+65,674Nov 16, 2026
Morgan Stanley142K0.07%US$107K+76,351Nov 13, 2026
Rhumbline Advisers141K0.07%US$106K+56,808Nov 10, 2026
DWS130K0.06%US$97,407−18,185Nov 6, 2026
LPL Financial LLC129K0.06%US$97,212−3,712Nov 6, 2026
T. Rowe Price122K0.06%US$92,000No changeNov 16, 2026
AQR Capital Management LLC120K0.06%US$89,763−604KNov 16, 2026
Invesco92,6100.04%US$69,549+9,856Nov 12, 2026
Sequoia Financial Advisors, LLC92,1400.04%US$69,198−10Nov 13, 2026
JPMorgan74,3820.04%US$60,175+11,607Nov 12, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.72,1520.03%US$54,186+3,681Nov 16, 2026
Corient Private Wealth LP64,5010.03%US$48,440+54,473Nov 16, 2026
Barclays61,7730.03%US$46,392+35,183Nov 6, 2026
New York State Common Retirement Fund58,7000.03%US$44,084No changeNov 17, 2026
Traphagen Investment Advisors LLC58,5900.03%US$44,002No changeOct 14, 2026
Virtu Financial LLC56,2490.03%US$42,000NewNov 17, 2026
Susquehanna53,8810.03%US$40,465+37,763Nov 16, 2026
Mml Investors Services, LLC50,0000.02%US$37,550No changeNov 13, 2026
AllianceBernstein47,2000.02%US$35,447No changeNov 16, 2026
Sargent Investment Group, LLC45,0000.02%US$33,795−20,000Nov 13, 2026
RBC44,6070.02%US$34,000+20,170Nov 16, 2026
Magnus Financial Group LLC40,9000.02%US$30,716−14,500Oct 21, 2026
Oppenheimer & Co Inc40,0000.02%US$30,040+10,000Oct 26, 2026
StoneX Group Inc.39,7480.02%US$32,267NewNov 3, 2026

This page holds 50 of 113 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund4.55M2.2%US$4.87M+1.52MJun 30, 2026
iShares Russell 2000 ETF3.57M1.7%US$3.82M+1.36MJun 30, 2026
Vanguard Extended Market Index Fund1.86M0.90%US$1.99M+815KJun 30, 2026
Fidelity Small Cap Index Fund1.58M0.76%US$1.38M+703KJul 31, 2026
iShares Russell 2000 Growth ETF1.4M0.67%US$1.49M+1.04MJun 30, 2026
Fidelity Extended Market Index Fund507K0.25%US$523K+8,292May 31, 2026
iShares Micro-Cap ETF498K0.24%US$533K+270KJun 30, 2026
Vanguard Russell 2000 Index Fund460K0.22%US$474K+13,831May 31, 2026
Schwab Small-Cap Index Fund363K0.18%US$316K+165KJul 31, 2026
Master Small Cap Index Series278K0.13%US$297K+158KJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
Nuveen Small Cap Blend Index Fund195K0.09%US$170K+105KJul 31, 2026
U.S. Small Cap Equity Fund187K0.09%US$163K−450KJul 31, 2026
Fidelity Total Market Index Fund171K0.08%US$176KNo changeMay 31, 2026
EQ/2000 Managed Volatility Portfolio155K0.07%US$166K+80,630Jun 30, 2026
Fidelity Series Total Market Index Fund140K0.07%US$144K+10,631May 31, 2026
U.S. Small Cap Equity Fund139K0.07%US$149KNo changeJun 30, 2026
Fidelity Small Cap Growth Index Fund139K0.07%US$148K+109KJun 30, 2026
LVIP State Street Small-Cap Index Fund113K0.05%US$121K+57,700Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund91,8400.04%US$98,269+63,722Jun 30, 2026
Small Cap Index Fund77,4210.04%US$82,840+28,828Jun 30, 2026
Fidelity Nasdaq Composite Index Fund77,1120.04%US$79,425No changeMay 31, 2026
Global X Russell 2000 ETF71,0300.03%US$61,910+31,390Jul 31, 2026
AQR Small Cap Momentum Style Fund64,2760.03%US$73,917First reportMar 31, 2026
Vanguard Balanced Index Fund56,0880.03%US$60,014+828Jun 30, 2026
Small-Cap Index Portfolio43,0870.02%US$46,103+26,038Jun 30, 2026
Vanguard Russell 2000 Value Index Fund39,7860.02%US$40,980+1,781May 31, 2026
State Street Small/Mid Cap Equity Index Portfolio39,2000.02%US$41,944+13,800Jun 30, 2026
Vanguard Russell 2000 Growth Index Fund35,2950.02%US$36,354+1,084May 31, 2026
Small Cap Index Fund33,7470.02%US$34,759No changeMay 31, 2026
1290 VT Micro Cap Portfolio33,4250.02%US$35,765+16,740Jun 30, 2026
ATM Small Cap Managed Volatility Portfolio32,0300.02%US$34,272+16,913Jun 30, 2026
NVIT Small Cap Index Fund31,1850.02%US$33,368+19,079Jun 30, 2026
EQ/Small Company Index Portfolio23,6000.01%US$25,252+12,500Jun 30, 2026
EQ/AB Small Cap Growth Portfolio23,6000.01%US$25,252+12,500Jun 30, 2026
DWS Small Cap Index VIP23,4190.01%US$25,058+10,616Jun 30, 2026
T. Rowe Price Small-Cap Index Fund22,4170.01%US$23,986+7,006Jun 30, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio22,1630.01%US$23,714+16,747Jun 30, 2026
BlackRock Small Cap Index V.I. Fund20,448<0.01%US$21,879+12,221Jun 30, 2026
Bridge Builder Small/Mid Cap Value Fund18,791<0.01%US$20,106No changeJun 30, 2026
Victory Extended Market Index Fund17,747<0.01%US$15,468+7,634Jul 31, 2026
SA Small Cap Index Portfolio17,413<0.01%US$15,177+9,543Jul 31, 2026
Nationwide Small Cap Index Fund13,939<0.01%US$12,149+8,016Jul 31, 2026
PD Small-Cap Growth Index Portfolio13,521<0.01%US$14,467+11,467Jun 30, 2026
Venerable Small Cap Index Fund11,891<0.01%US$12,723+6,158Jun 30, 2026
SmallCap Growth Fund I11,385<0.01%US$9,923+9,272Jul 31, 2026
Vanguard Russell 3000 Index Fund9,709<0.01%US$10,000No changeMay 31, 2026
iShares Russell Small/Mid-Cap Index Fund9,222<0.01%US$8,038No changeJul 31, 2026
CVT Russell 2000 Small Cap Index Portfolio7,067<0.01%US$7,562No changeJun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund5,596<0.01%US$5,988No changeJun 30, 2026
ProShares Russell 2000 High Income ETF4,241<0.01%US$4,368+337May 31, 2026

This page holds 50 of 67 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Matheis Dennis
Director
Buy245,000USD 1.00US$245KMay 20, 2026

Big stakes

HolderStakeSharesDate
PAVmed Inc.27.50%38.8MFeb 3, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dennis M. McGrath
Other companies: Citius Oncology, Inc. (Director · Since at least Aug 12, 2024); Citius Pharmaceuticals, Inc. (Director · Since at least Feb 7, 2023); PAVmed Inc. (President and CFO · Since at least Feb 14, 2018); DarioHealth Corp. (Board Member · Since at least Oct 23, 2017)
Chief Financial Officer · Since at least Oct 13, 2021
Jacque J. Sokolov
Other companies: Medcath Corp (Director · Oct 2, 2006 – Aug 24, 2012 · Past); Hospira Inc (Director · Jun 30, 2006 – Sep 3, 2015 · Past)
Board Member · Since at least Oct 13, 2021
James L. Cox
Other companies: Adagio Medical Holdings, Inc (Director · Since at least Jul 31, 2024); PAVmed Inc. (Director · Apr 1, 2021 – Feb 22, 2024 · Past)
Director · Since at least Oct 13, 2021
John Palumbo
Other companies: DarioHealth Corp. (Chairman of the Board, Board Member · Since at least Apr 10, 2026); Cencora, Inc. (Director · Apr 13, 2026 – Nov 5, 2026 · Past)
Board Member · Since at least Sep 22, 2025
Lishan Aklog
Other companies: PAVmed Inc. (Chairman, Chief Executive Officer · Since at least Jan 29, 2016); Viveon Health Acquisition Corp (Director · Dec 22, 2020 – Dec 23, 2020 · Past)
Chairman, Chief Executive Officer · Since at least Oct 13, 2021
Aster Angagaw
Other companies: Accendra Health, Inc. (Director · Mar 1, 2021 – Apr 29, 2021 · Past)
Director · Oct 13, 2021 – Feb 18, 2022 · Past
Brian deGuzman
Other companies: PAVmed Inc. (Executive Vice President, Chief Technology & Compliance Officer · Since at least Jan 29, 2016)
Chief Technology & Compliance Officer · Since at least Nov 5, 2026
Debra White
Other companies: PAVmed Inc. (Director · Since at least Apr 22, 2021)
Director · Since at least Aug 1, 2022
Deepika A. Lakhani
Other companies: PAVmed Inc. (Senior Vice President, Chief Regulatory & Quality Officer · Since at least Nov 5, 2026)
Senior Vice President, Chief Regulatory & Quality Officer · Since at least Nov 5, 2026
Dennis Matheis
Other companies: DarioHealth Corp. (Board Member · Since at least Jul 2, 2020)
Director · Since at least May 6, 2024
All 19 people
PersonSeat
Michael Gordon
Other companies: PAVmed Inc. (Executive Vice President, General Counsel & Corporate Secretary · Since at least May 31, 2022)
General Counsel & Corporate Secretary · Since at least May 31, 2022
Ronald M Sparks
Other companies: PAVmed Inc. (Director · Since at least Jan 29, 2016)
Director · Since at least Oct 13, 2021
Shaun O'Neil
Other companies: PAVmed Inc. (Executive Vice President, Chief Operating Officer · Since at least Feb 22, 2022)
President & Chief Operating Officer · Since at least Mar 18, 2022
Stanley N. Lapidus
Other companies: T2 Biosystems, Inc. (Director · Jun 17, 2016 – Jun 11, 2019 · Past)
Vice-Chairman · Since at least Oct 13, 2021
Victoria T. Lee
Other companies: PAVmed Inc. (Executive Vice President, Chief Medical Officer · Since at least Dec 9, 2025)
Executive Vice President, Chief Medical Officer · Since at least Mar 23, 2026
David F WurtmanChief Medical Officer · Oct 13, 2021 – Oct 13, 2021 · Past
Debbie WhiteDirector · Since at least Nov 4, 2026
Ron SparksDirector · Since at least Nov 4, 2026
Suman M. VermaSenior Vice President, Chief Scientific Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Lucid Diagnostics Inc.